基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 来沙木单抗
  • (Lexatumumab)Biosimilar Reference Antibody-GS40381
  • (Lexatumumab)Biosimilar Reference Antibody-GS40381

1/2

(Lexatumumab)Biosimilar Reference Antibody-GS40381

Lexatumumab
300 100μg 起订
湖北 更新日期:2026-03-16

武汉迈思生物科技有限公司

VIP1年
联系人:市场
电话:027-65523427拨打
手机:18007167883 拨打
邮箱:Service@mabnus.com

产品详情:

英文名称:
Lexatumumab
CAS号:
845816-02-6
品牌:
Mabnus
产地:
武汉
保存条件:
store at -20°C or -80°C. Avoid repeated freeze.
纯度规格:
>95% by SDS-PAGE
重组:
应用:
ELISA;FC;Functional Assays;IF
种属反应性:
Human
宿主:
Genetically human
偶联物:
靶点:
TNFRSF10B/CD262/DR5/TRAILR2
免疫原:
TNFRSF10B/CD262/DR5/TRAILR2
亚型:
IgG1 - lambda
验证方法:
(Lexatumumab)Biosimilar Reference Antibody(GS40381) on SDS-PAGE under non-reducing (NR) and reducing (R) condition.

货号:GS40381

Lexatumumab (also known as HGS-ETR2) is a fully human monoclonal antibody that specifically targets and activates TRAIL receptor 2 (TRAIL-R2, also known as DR5 or TNFRSF10B), a member of the tumor necrosis factor (TNF) receptor superfamily. As an agonist antibody, it binds to DR5 and mimics the action of the natural ligand TRAIL (TNF-related apoptosis-inducing ligand), thereby inducing apoptosis (programmed cell death) in cancer cells that express the receptor. It was developed as a potential therapeutic agent for the treatment of various advanced solid tumors and hematologic malignancies, based on the premise of selectively triggering cell death in tumors while sparing most normal cells.



Lexatumumab;

公司简介

武汉迈思生物科技有限公司立足于解决行业内功能活性蛋白表达及高亲和力、高灵敏度抗体开发难的痛点,依托自建的两大核心技术平台:哺乳动物细胞蛋白表达平台和单个B细胞抗体开发平台,竭诚为广大科研机构、高等院校、IVD企业、医药企业等提供一站式蛋白表达及抗体开发相关产品和技术服务。

成立日期 (5年)
注册资本 壹佰伍拾万圆人民币
员工人数 10-50人
年营业额 ¥ 1000万-5000万
经营模式 工厂,试剂,定制,服务
主营行业 抗体,蛋白组学

Lexatumumab相关厂家报价 更多

内容声明
拨打电话 立即询价